4//SEC Filing
ACADIA PHARMACEUTICALS INC 4
Accession 0001415889-14-002690
$ACADCIK 0001070494operating
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 6:06 PM ET
Size
12.1 KB
Accession
0001415889-14-002690
Insider Transaction Report
Form 4
Wells William McDowall
Director
Transactions
- Sale
Common Stock
2014-09-02$26.76/sh−15,000$401,400→ 15,000 total - Exercise/Conversion
Stock Option (right to buy)
2014-09-02−10,000→ 0 totalExercise: $1.36Exp: 2022-06-07→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock option (right to buy)
2014-09-02−20,000→ 24,117 totalExercise: $1.36Exp: 2022-06-07→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2014-09-02$1.36/sh+30,000$40,800→ 30,000 total - Sale
Common Stock
2014-09-02$27.00/sh−15,000$405,000→ 0 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2014.
- [F2]25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following June 8, 2012.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070494
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 6:06 PM ET
- Size
- 12.1 KB